 |
市场调查报告书
商品编码
1349985
白血球消除设备市场:各设备类型，各用途，各终端用户，各地区:市场规模，占有率，展望，机会分析，2023年～2030年Leukapheresis Devices Market, By Device Type, By Application, By End User, By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 |
||||||
2023年全球白血球分离设备市场规模预估为2,990万美元，预测期间内（2023-2030年）复合年增长率为7.9%。
| 报告范围 | 报告详细资料 | ||
|---|---|---|---|
| 基准年 | 2022 | 2023 年市场规模 | 2990万美元 |
| 过去的资料 | 2018年至2021年 | 预测期间 | 2023-2030 |
| 预测 2023-2030 年复合年增长率： | 7.90% | 2030年价值预测 | 5,100万美元 |
白血病是一种从血液样本中分离白血球的医疗程序。进行此手术是为了减少血液恶性肿瘤患者的白血球数量。因此，白血球分离机是一种用于促进此过程的医疗设备。临床研究中白血球检测需求的不断增长是推动市场成长的主要因素之一。与捐血相关的活动越来越多，加上技术创新和进步不断增加，也是市场成长的决定因素。个人健康意识的提高、对白血球（WBC）分离过程的认可度提高以及医疗旅游业的兴起是创造进一步利润丰厚的市场成长机会的其他关键因素。
市场动态
这份全球白血球去除设备市场报告涵盖了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场占有率、国家和本地市场参与者的影响、新收入来源从市场监管的角度进行分析变化、策略市场成长分析、市场规模、类别市场成长、应用利基和优势、产品批准、产品发布、区域市场分析以及市场技术创新的详细资讯。例如，2021 年 12 月，正在开发突破性医疗器材以解决血流感染治疗中未满足的临床需求的 ExThera Medical 宣布，旭化成集团有限公司的核心营运公司旭化成医疗公司已与旭化成医疗公司签署合作协议。 ExThera 的Seraph 100 Microbind 亲和血液过滤器(Seraph 100) 在日本的独家经销协议。根据该协议，ExThera Medical 和旭化成医疗有限公司将共同努力获得 Seraph 100 在日本的上市许可。由于白血病盛行率不断增加，全球白血球分离设备市场预计在预测期内将显着增长。例如，2022 年 6 月，Terumo Blood 专门从事血液成分采集、治疗性单采和细胞技术，而 Cell Technologies 专门从事血液成分采集、治疗性单采和细胞技术的产品、软体和服务组合。该公司与领先的医疗技术公司、BioBridge Global 的子公司GenCure 签订了一项新的合作协议，以扩展和统一细胞和基因治疗製造解决方案。
本调查的主要特征
- 本报告提供以2022年为基准年的预测期间（2023-2030 年）之全球白血球消除设备市场的市场规模和復合年增长率（CAGR %）相关的详区隔析。
- 并阐明不同部门市场的潜在收入机会，说明该市场具有魅力的投资主张矩阵。
- 同时并提供市场推动因素和限制、机会、新产品发布或批准、市场趋势、区域前景和主要参与者采用的竞争战略等重要考察。
- 并基于企业亮点，各类型投资组合、主要焦点、财务业绩和市场策略等参数，介绍全球白血球消除设备市场的主要参与者之企业简介。
- 藉由该报告提供的洞察，将能帮助营销人员和公司高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
- 全球白血球消除设备市场报告配合该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
- 利益相关者可以透过全球白血球消除设备市场用于分析的各种战略矩阵来帮助他们更容易做下决策。
目录
第1章 调查目的与前提条件
- 调查目的
- 前提条件
- 简称
第2章 市场概况
- 报告概要
- 市场定义和范围
- 摘要整理
- Coherent Opportunity Map(COM)
第3章 市场动态，法规，趋势分析
- 市场动态
- 促进因素
- 阻碍因素
- 市场机会
- 影响分析
- 最近的产品上市
- 流行病学
- 合併，收购，联盟
- 法规情势
- 主要的发展
- PEST分析
第4章 白血球消除设备的全球市场:COVID-19影响分析
- 经济影响
- COVID-19流行病学
- 供需的影响
第5章 白血球消除设备的全球市场:各设备类型，2018-2030年
- 单采设备
- 白血球消除管柱及细胞分离器
- 白血球消除过滤器
- 白血球分离术抛弃式
第6章 白血球消除设备的全球市场:各用途，2018-2030年
- 调查用途
- 治疗用途
第7章 白血球消除设备的全球市场:各终端用户，2018-2030年
- 医院
- 学术·研究机关
- 製药·生物科技企业
- 血液成分供应商
- 血液中心
第8章 白血球消除设备的全球市场:各地区，2018-2030年
- 北美
- 美国
- 加拿大
- 欧洲
- 英国
- 德国
- 义大利
- 法国
- 西班牙
- 俄罗斯
- 其他欧洲
- 亚太地区
- 中国
- 印度
- 日本
- ASEAN
- 澳洲
- 韩国
- 其他亚太地区
- 南美
- 巴西
- 墨西哥
- 阿根廷
- 其他南美国家
- 中东
- GCC
- 以色列
- 其他中东
- 非洲
- 北非
- 中非
- 南非
- 其他非洲国家
第9章 企业简介
- Asahi Kasei Medical Co. Ltd.
- 产品系列
- 主要的焦点
- 业绩
- 策略
- Haemonetics Corporation
- 产品系列
- 主要的焦点
- 业绩
- 策略
- Terumo BCT Inc.
- 产品系列
- 主要的焦点
- 业绩
- 策略
- STEMCELL Technologies Inc.
- 产品系列
- 主要的焦点
- 业绩
- 策略
- Fresenius SE & Co. KGaA
- 产品系列
- 主要的焦点
- 业绩
- 策略
- BioIVT
- 产品系列
- 主要的焦点
- 业绩
- 策略
- Grifols, S.A
- 产品系列
- 主要的焦点
- 业绩
- 策略
- HemaCare
- 产品系列
- 主要的焦点
- 业绩
- 策略
- Braun Melsungen AG
- 产品系列
- 主要的焦点
- 业绩
- 策略
- Caltag Medsystems Limited
- 产品系列
- 主要的焦点
- 业绩
- 策略
- AllCells
- 产品系列
- 主要的焦点
- 业绩
- 策略
- StemExpress
- 产品系列
- 主要的焦点
- 业绩
- 策略
- PPA
- 产品系列
- 主要的焦点
- 财务效能
- 策略
- Cellero
- 产品系列
- 主要的焦点
- 财务效能
- 策略
- Precision for Medicine, Inc
- 产品系列
- 主要的焦点
- 业绩
- 策略
- The Intelligent Tissue Group Lonza
- 产品系列
- 主要的焦点
- 业绩
- 策略
- Lmb Technologie GmbH
- 产品系列
- 主要的焦点
- 业绩
- 策略
- Kaneka Medical Europe N.V.
- 产品系列
- 主要的焦点
- 业绩
- 策略
- Key Biologics, LLC.
- 产品系列
- 主要的焦点
- 业绩
- 策略
第10章 章节
- 分析师的见解
- 参考文献
- 调查手法
The global leukapheresis devices market is estimated to be valued at US$ 29.9 Million in 2023 and is expected to exhibit a CAGR of 7.9% during the forecast period (2023-2030).
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2022 | Market Size in 2023: | US$ 29.9 Mn |
| Historical Data for: | 2018 to 2021 | Forecast Period: | 2023 - 2030 |
| Forecast Period 2023 to 2030 CAGR: | 7.90% | 2030 Value Projection: | US$ 51 Mn |
Leukaemia is a medical procedure that involves separating white blood cells from a sample of blood. The procedure is undergone to reduce the quantity of white blood cells in patients wuth hematological malignancies. Therefore, leukapheresis devices are the medical devices that are used to facilitate this procedure. The surge in demand for leukopaks in clinical research is one of the major factors fostering the growth of the market. Growth in the number of activities associated with blood donations coupled with growing innovations and advancements in technologies is another market growth determinant. Rising health awareness among individuals, growing approvals for processes of isolating white blood cells (WBC), and rising medical tourism are other important factors that will further generate lucrative market growth opportunities.
Market Dynamics
This global leukapheresis devices market report provides details of recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, and technological innovations in the market. For instance, In December 2021, ExThera Medical develops revolutionary medical devices that address unmet clinical needs in the treatment of bloodstream infections and Asahi Kasei Medical, a core operating company of the Asahi Kasei Group, entered into an exclusive distribution agreement in Japan for ExThera's Seraph 100 Microbind Affinity Blood Filter (Seraph 100). As per the agreement structure, ExThera Medical and Asahi Kasei Medical will collaborate to obtain regulatory approval for Seraph 100 for commercialization in Japan. The global leukapheresis devices market is expected to witness significant growth during the forecast period, owing to the increasing prevalence of leukemia. For instance, in June 2022, Terumo Blood is in blood component, therapeutic apheresis and cellular technologies and Cell Technologies, a medical technology company specializing in a portfolio of products, software, and services for blood component collection, therapeutic apheresis, and cellular technologies, announced it had signed a new collaborative agreement with GenCure, a subsidiary of BioBridge Global, to extend and unify cell and gene therapy manufacturing solutions.
Key features of the study:
- This report provides an in-depth analysis of the global leukapheresis devices market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global leukapheresis devices market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Asahi Kasei Medical Co. Ltd., Haemonetics Corporation, Terumo BCT Inc., STEMCELL Technologies Inc., Fresenius SE & Co. KGaA, BioIVT, Grifols, S.A, HemaCare, B. Braun Melsungen AG, Caltag Medsystems Limited, AllCells, StemExpress, PPA, Cellero, Precision for Medicine, Inc., The Intelligent Tissue Group Lonza, BioIVT, Lmb Technologie GmbH, Kaneka Medical Europe N.V. and Key Biologics, LLC.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding its future product launches, type up-gradation, market expansion, and marketing tactic
- The global leukapheresis devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global leukapheresis devices market
Detailed Segmentation:
- Global Leukapheresis Devices Market, By Device Type:
- Apheresis Devices
- Leukapheresis Columns & Cell Separators
- Leukoreduction Filters
- Leukapheresis Disposables
- Global Leukapheresis Devices Market, By Application :
- Research Applications
- Therapeutic Applications
- Global Leukapheresis Devices Market, By End User:
- Hospitals
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Blood Component Providers
- Blood Centers
- Global Leukapheresis Devices Market , By Region:
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Asahi Kasei Medical Co. Ltd.
- Haemonetics Corporation
- Terumo BCT Inc.
- STEMCELL Technologies Inc.
- Fresenius SE & Co. KGaA
- BioIVT, Grifols, S.A
- HemaCare
- B.Braun Melsungen AG
- Caltag Medsystems Limited
- AllCells
- StemExpress
- PPA
- Cellero
- Precision for Medicine, Inc.
- The Intelligent Tissue Group Lonza
- BioIVT
- Lmb Technologie GmbH
- Kaneka Medical Europe N.V.
- Key Biologics, LLC.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Device Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Product Launches
- Epidemiology
- Merger, Acquisition, and Collaboration
- Regulatory Scenario
- Key Developments
- PEST Analysis
4. Global Leukapheresis Devices Market- COVID-19 Impact Analysis
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
5. Global Leukapheresis Devices Market, By Device Type, 2018-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Apheresis Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Leukapheresis Columns & Cell Separators
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Leukoreduction Filters
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Leukapheresis Disposables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
6. Global Leukapheresis Devices Market, By Application, 2018-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Research Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Therapeutic Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
7. Global Leukapheresis Devices Market, By End User, 2018-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Academic & Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Pharmaceutical & Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Blood Component Providers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Blood Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
8. Global Leukapheresis Devices Market, By Region, 2018-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- North America
- Introduction
- Market Size and Forecast, By Device Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Application, 2018-2030, (US$ Mn)
- Market Size and Forecast, By End User, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, 2018-2030, (US$ Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, By Device Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Application, 2018-2030, (US$ Mn)
- Market Size and Forecast, By End User, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, 2018-2030, (US$ Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Device Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Application, 2018-2030, (US$ Mn)
- Market Size and Forecast, By End User, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, 2018-2030, (US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, By Device Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Application, 2018-2030, (US$ Mn)
- Market Size and Forecast, By End User, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, 2018-2030, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, By Device Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Application, 2018-2030, (US$ Mn)
- Market Size and Forecast, By End User, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, 2018-2030, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Device Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Application, 2018-2030, (US$ Mn)
- Market Size and Forecast, By End User, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country/Region, 2018-2030, (US$ Mn)
- North Africa
- Central Africa
- South Africa
- Rest of Africa
9. Company Profiles
- Asahi Kasei Medical Co. Ltd.*
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Haemonetics Corporation
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Terumo BCT Inc.
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- STEMCELL Technologies Inc.
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Fresenius SE & Co. KGaA
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- BioIVT
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Grifols, S.A
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- HemaCare
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Braun Melsungen AG
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Caltag Medsystems Limited
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- AllCells
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- StemExpress
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- PPA
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Cellero
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Precision for Medicine, Inc.
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- The Intelligent Tissue Group Lonza
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Lmb Technologie GmbH
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Kaneka Medical Europe N.V.
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Key Biologics, LLC.
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
10. Section
- Analyst view
- References
- Research Methodology
About us and Sales Contact*Browse 36 market data tables and 33 figures on "Leukapheresis Devices Market "- Global Forecast to 2030
